FLUDEOXYGLUCOSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fludeoxyglucose, and what generic alternatives are available?
Fludeoxyglucose is a drug marketed by Downstate Clincl, 3d Imaging Drug, Bamf, Biomedcl Res Fdn, Brigham Womens, Cardinal Health 414, Childrens Hosp Mi, Essential Isotopes, Feinstein, Hot Shots Nm Llc, Isologic Innovative, Jubilant Draximage, Kettering Medctr, Kreitchman Pet Ctr, Ma General Hosp, Mcprf, Mem Sloan-kettering, Methodist Hosp Res, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Northland, Nukemed, Petnet, Pharmalogic, Pharmalogic Hldgs, Precision Nuclear, Queen Hamamatsu Pet, Sofie, Trustees Univ Pa, Ucla Biomedical, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Michigan, Univ Southern Ca, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Utah Cyclotron, Weill Medcl Coll, Wisconsin, and Wusm Cyclotron. and is included in forty-four NDAs.
The generic ingredient in FLUDEOXYGLUCOSE is fludeoxyglucose f-18. There are eight drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the fludeoxyglucose f-18 profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLUDEOXYGLUCOSE?
- What are the global sales for FLUDEOXYGLUCOSE?
- What is Average Wholesale Price for FLUDEOXYGLUCOSE?
Summary for FLUDEOXYGLUCOSE
| US Patents: | 0 |
| Applicants: | 41 |
| NDAs: | 44 |
| Drug Prices: | Drug price information for FLUDEOXYGLUCOSE |
| What excipients (inactive ingredients) are in FLUDEOXYGLUCOSE? | FLUDEOXYGLUCOSE excipients list |
| DailyMed Link: | FLUDEOXYGLUCOSE at DailyMed |
US Patents and Regulatory Information for FLUDEOXYGLUCOSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univ Southern Ca | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 209341-001 | Dec 16, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Queen Hamamatsu Pet | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203771-001 | Aug 31, 2015 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Univ Utah Cyclotron | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 204498-001 | Jun 23, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Petnet | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 079086-001 | Feb 25, 2011 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sofie | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203591-001 | Aug 31, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmalogic | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 204264-001 | Dec 18, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Downstate Clincl | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INJECTION | 020306-001 | Aug 19, 1994 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
